DIETARY SALT SODIUM INCREASES STOMACH CANCER RISK Cancer of the stomach occurs only about half as commonly today in the United States as it did 30 years ago, but it remains one of the bad actor cancer...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the results of the Phase II study TDM4450g in people with previously untreated HER2-positive metastatic breast cancer (mBC).
Data presented this week at a European cancer conference suggests that the association between plasma VEGF-A protein levels and patient response to Genentech's VEGF inhibitor Avastin may be limited to certain types of cancer.
DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/fc8a05/global_gastric_can) has announced the addition of the "Global Gastric Cancer Drug Pipeline Capsule - 2011" report to their offering. Fore Pharma's latest repor